Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624
This examiner grants 74% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18117966 | NOVEL HETEROCYCLIC COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17869755 | NOVEL HETEROCYCLIC COMPOUNDS | Non-Final OA | Hoffmann-La Roche Inc. |
| 17997013 | Small Molecule Inhibitors That Block the Budding of Enveloped Viruses | Non-Final OA | Northwestern University |
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Non-Final OA | Mindset Pharma Inc. |
| 16948467 | TLR7/8 ANTAGONISTS AND USES THEREOF | Non-Final OA | Merck Patent GmbH |
| 18322445 | SMALL MOLECULE DEGRADERS OF THE BROMODOMAIN AND PHD FINGER TRANSCRIPTION FACTOR | Non-Final OA | Regents of the University of Minnesota |
| 17308555 | ARTICLE INCLUDING PHTHALOCYANINE DYES | Final Rejection | VIAVI SOLUTIONS INC. |
| 18230392 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | Final Rejection | Shionogi & Co., Ltd. |
| 18468885 | HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17016158 | METHOD AND COMPOSITION FOR ADMINISTERING PROSTAGLANDINS | Non-Final OA | MannKind Corporation |
| 18271523 | NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | Non-Final OA | SHANGHAITECH UNIVERSITY |
| 18021760 | A PRECIPITATION PROCESS FOR AMORPHOUS LETERMOVIR | Non-Final OA | Lupin Limited |
| 18414198 | MORPHIC FORMS OF HEXADECYLOXYPROPYL-PHOSPHONATE ESTERS AND METHODS OF SYNTHESIS THEREOF | Non-Final OA | EMERGENT BIODEFENSE OPERATIONS LANSING LLC |
| 18577856 | NEW SELECTIVE ANGIOTENSIN II COMPOUNDS | Non-Final OA | VICORE PHARMA AB |
| 18561152 | FORMULATIONS OF PSILOCYBIN | Non-Final OA | CYBIN IRL LIMITED |
| 18036549 | KINASE MODULATORS AND METHODS OF USE THEREOF | Non-Final OA | NEURON23, INC. |
| 18463112 | COMPOUNDS AND METHOD FOR PREPARING THE SAME | Non-Final OA | NANJING GRITPHARMACO., LTD. |
| 18461179 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Final Rejection | Pardes Biosciences, Inc. |
| 17779522 | 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Final Rejection | SHANGHAI KUNHENG PHARMA-TECH CO., LTD |
| 18210068 | INTERMEDIATE OF BILIVERDIN, AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | WUHAN JIANMIN DAPENG PHARMACEUTICAL CO., LTD. |
| 18256114 | BENZOPYRAZOLE INHIBITORS OF SARM1 | Non-Final OA | Disarm Therapeutics, Inc. |
| 18001695 | COMPOUNDS, COMPOSITIONS AND METHODS | Final Rejection | Tenvie Therapeutics, Inc. |
| 18252737 | TYROSINE KINASE 2 (TYK2) DEGRADATION COMPOUNDS AND METHODS OF USE | Non-Final OA | CULLGEN (SHANGHAI), INC. |
| 18316994 | MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS | Non-Final OA | Neumora Therapeutics, Inc. |
| 18014059 | 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE | Non-Final OA | REMIX THERAPEUTICS INC. |
| 18023405 | PREPARATION METHOD FOR NOVEL RHO-RELATED PROTEIN KINASE INHIBITOR AND INTERMEDIATE IN PREPARATION METHOD | Non-Final OA | BEIJING TIDE PHARMACEUTICAL CO., LTD. |
| 18003200 | PREPARATION METHOD FOR FUSED PYRAZOLE-TYPE COMPOUND | Non-Final OA | WUHAN CREATERNA SCIENCE AND TECHNOLOGY CO., LTD. |
| 17777027 | IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF | Final Rejection | GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD |
| 17910838 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | Anima Biotech Inc. |
| 17780891 | PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF | Final Rejection | Captor Therapeutics S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy